Skip to main content
. 2018 Aug 27;3(10):968–977. doi: 10.1001/jamacardio.2018.2936

Figure 2. Cumulative 12-Month Incidence of Major Adverse Cardiac, Cerebrovascular, and Renal Events and Heart Failure Events Requiring Intravenous Diuretic Treatment, Stratified by Treatment Group.

Figure 2.

MACCRE indicates major adverse cardiac, cerebrovascular, and renal events.